In our study, asymptomatic individuals with elevated AFP levels up to 168 ng/mL showed a higher serum total bilirubin level, lower ALT level, lower BMI, and lower probability of NAFLD-fibrosis than the age- and sex-matched control group. Here, AFP is linked to metabolic dysfunction-associated steatotic liver disease.